Mediotek Health Systems Profile
Key Indicators
- Authorised Capital ₹ 1.10 Cr
- Paid Up Capital ₹ 1.09 Cr
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 M
- Revenue Growth -17.11%
- Profit Growth 6.57%
- Ebitda 8.73%
- Net Worth -80.91%
- Total Assets -3.56%
About Mediotek Health Systems
Mediotek Health Systems Private Limited (MHSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 05 February 2016 (Eight years and 11 months 27 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.10 Cr and a paid-up capital of Rs 1.09 Cr.
The company currently has active open charges totaling ₹4.50 M.
Sharmila Devadoss and Annamalai Devadoss serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74900TN2016PTC104033
-
Company No.
104033
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Feb 2016
-
Date of AGM
23 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Mediotek Health Systems?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharmila Devadoss
|
Director | 05-Feb-2016 | Current |
|
Annamalai Devadoss
|
Director | 05-Feb-2016 | Current |
Financial Performance of Mediotek Health Systems.
Mediotek Health Systems Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 17.11% decrease. The company also saw a slight improvement in profitability, with a 6.57% increase in profit. The company's net worth observed a substantial decline by a decrease of 80.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediotek Health Systems?
In 2021, Mediotek Health Systems had a promoter holding of 87.04% and a public holding of 12.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Devadoss Hospital Private LimitedAnnamalai Devadoss is a mutual person
Charges (Loans)
₹0.45 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Sep 2016 | Others | ₹4.50 M | Open |
How Many Employees Work at Mediotek Health Systems?
Unlock and access historical data on people associated with Mediotek Health Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediotek Health Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediotek Health Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
